Doss-Gollin S, Thomas S, Brook B, et al. npj Vaccines. 2023;8(1):163. doi:10.1038/s41541-023-00759-y
- November 7, 2023
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen
Share on linkedin
Share on reddit
Share on facebook
Share on twitter
Share on email